SMALL RNA AS ANTIAGING COSMECEUTICALS 467 (58) K. Tsukahara, Y. Takema, T. Fujimura, S. Moriwaki, T. Kitahara, S. Imayama, and G. Imokawa. All- trans retinoic acid promotes the tortuosity of elastic fi bres in rat skin, Br. J. Dermatol., 140(6), 1048– 1053 (1999). (59) P. Zhang, A Huang, J Ferruzzi, R.P. Mecham, B.C. Starcher, G. Tellides, J.D. Humphrey, F.J. Giordano, L.E. Niklason, and W.C. Sessa, Inhibition of microRNA-29 enhances elastin levels in cells haploinsuf- fi cient for elastin and in bioengineered vessels—brief report, Arterioscler Thromb. Vasc. Biol., 32(3), 756–759(2012). (60) C.E. Ott, J. Grünhagen, M. Jäger, D. Horbelt, S. Schwill, K. Kallenbach, G. Guo, T. Manke, P. Knaus, S. Mundlos, and P.N. Robinson, MicroRNAs differentially expressed in postnatal aortic devel- opment downregulate elastin via 3’UTR and coding-sequence binding sites, PLoS One, 6(1), e16250 (2011). (61) X.R. Dong, and M.W. Majesky, Restoring elastin with microRNA-29, Arterioscler Thromb. Vasc. Biol., 32(3), 548–551 (2012). (62) E. van Rooij, L.B. Sutherl, J.E. Thatcher, J.M. DiMaio, R.H. Naseem, W.S. Marshall, J.A. Hill, and E.N. Olson, Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fi brosis, Proc. Natl. Acad. Sci. U S A, 105(35), 13027–13032 (2008). (63) B. Maurer, J. Stanczyk, A. Jüngel, A. Akhmetshina, M. Trenkmann, M. Brock, O. Kowal-Bielecka, R.E. Gay, B.A. Michel, J.H. Distler, S. Gay, and O. Distler, MicroRNA-29, a key regulator of colla- gen expression in systemic sclerosis, Arthritis Rheum., 62(6), 1733–1743 (2010). (64) K.C. Chen, Y.S. Wang, C.Y. Hu, W.C. Chang, Y.C. Liao, C.Y. Dai, and S.H. Juo, OxLDL up-regulates microRNA-29b, leading to epigenetic modifi cations of MMP-2/MMP-9 genes: A novel mechanism for cardiovascular diseases, FASEB J., 25(5), 1718–1728 (2011). (65) R. Bazin, and C. Fanchon, Equivalence of face and volar forearm for the testing of moisturizing and fi rming effect of cosmetics in hydration and biomechanical studies, Int. J. Cosmet. Sci., 28(6), 453–460 (2006). (66) D. Helbig, and U. Paasch, Molecular changes during skin aging and wound healing after fractional ablative photothermolysis, Skin Res. Technol., 17(1), 119–128 (2011). (67) I. Ghersetich, T. Lotti, G. Campanile, C. Grappone, and G. Dini, Hyaluronic acid in cutaneous intrin- sic aging, Int. J. Dermatol., 33(2): 119–122 (1994). (68) J. Chompoo, A. Upadhyay, M. Fukuta, and S. Tawata, Effect of Alpinia zerumbet components on antioxidant and skin diseases-related enzymes, Complement Altern. Med., 12, 106 (2012). (69) F. Barla, H. Higashijima, S. Funai, K. Sugimoto, N. Harada, R. Yamaji, T. Fujita, Y. Nakano, and H. Inui, Inhibitive effects of alkyl gallates on hyaluronidase and collagenase, Biosci. Biotechnol. Biochem., 73(10), 2335–2337 (2009). (70) J.X. Tan, G.S. Ren, G. Tu, and Z. Ai, [Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cell], Ai Zheng, 25(7), 844–848 (2006). (71) R.D. Sinclair, and R.P. Dawber, Androgenetic alopecia in men and women, Clin. Dermatol., 19(2). 167–178 (2001). (72) U. Blume-Peytavi, and S. Hahn, Medical treatment of hirsutism, Dermatol. Ther., 21(5), 329–339 (2008). (73) R. Yi, D. O’Carroll, H.A. Pasolli, Z. Zhang, F.S. Dietrich, A. Tarakhovsky, and E. Fuchs, Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs, Nat. Genet., 38(3), 356– 362 (2006). (74) M. Ueda, and Y. Nishino, Cell-based cytokine therapy for skin rejuvenation, J. Craniofac. Surg., 21(6), 1861–1866 (2010). (75) K. Takahashi, and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors, Cell, 126, 663–676 (2006). (76) F. Anokye-Danso, C.M. Trivedi, and D. Juhr, Highly effi cient miRNA mediated reprogramming of mouse and human somatic cells to pluripotency, Cell Stem Cell, 8, 376–388 (2011). (77) N. Miyoshi, H. Ishii, and H. Nagano, Reprogramming of mouse and human cells to pluripotency using mature microRNAs, Cell Stem Cell, 8, 633–638 (2011). (78) M.A. Li, and L. He, MicroRNAs as novel regulators of stem cell pluripotency and somatic cell repro- gramming, Bioessays, 34(8), 670–680 (2012). (79) A. Ammala, Biodegradable polymers as encapsulation materials for cosmetics and personal care mar- kets, Int. J. Cosmet. Sci., 35(2):113–124 (2013).

JOURNAL OF COSMETIC SCIENCE 468 (80) T.R. Singh, M.J. Garland, C.M. Cassidy, K. Migalska, Y.K. Demir, S. Abdelghany, E. Ryan, A.D. Woolfson, and R.F. Donnelly, Microporation techniques for enhanced delivery of therapeutic agents, Recent Pat. Drug Deliv. Formul., 4(1), 1–17 (2010). (81) K. Kigasawa, K. Kajimoto, S. Hama, A. Saito, K. Kanamura, and K. Kogure, Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat, Int. J. Pharm., 383(1–2), 157–160 (2010). (82) K.E Broderick, A. Chan, F. Lin, X. Shen, G. Kichaev, A.S. Khan, J. Aubin, T.S Zimmermann, and N.Y. Sardesai, Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation, Mol. Ther. Nucleic Acids, 1(2), e11 (2012). (83) M.A. Tran, R. Gowda, A. Sharma, E.J. Park, J. Adair, M. Kester, N.B. Smith, and G.P. Robertson, Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development, Cancer Res., 68(18), 7638–7649 (2008). (84) M.F. Lara, E. González-González, T.J. Speaker, R.P. Hickerson, D. Leake, L.M. Milstone, C.H. Contag, and R.L. Kaspar, Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays, Hum. Gene. Ther., 23(8), 816–823 (2012). (85) P. Ritprajak, M. Hashiguchi, and M. Azuma, Topical application of cream emulsifi ed CD86 siRNA ameliorates allergic skin disease by targeting Cutaneous dendritic cells, Mol. Ther., 16(7), 1323–1330 (2008). (86) X. Wang, W. Xu, S. Mohapatra, X. Kong, X. Li, R.F. Lockey, and S.S. Mohapatra, Prevention of airway infl ammation with topical cream containing imiquimod and small interfering RNA for natri- uretic peptide receptor, Genet. Vaccines Ther., 15, 6–7 (2008). (87) D. Zheng, D.A. Giljohann, D.L. Chen, M.D. Massich, X.Q. Wang, H. Iordanov, C.A. Mirkin, and A.S. Paller, Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation, Proc. Natl. Acad. Sci. U S A, 109(30), 11975–11980 (2012). (88) S.A. Nasrollahi, C. Taghibiglou, E. Azizi, and E.S. Farboud, Cell-penetrating peptides as a novel transdermal drug delivery system, Chem. Biol. Drug. Des., 80(5), 639–646 (2012). (89) C.M. Lin, K. Huang, Y. Zeng, X.C. Chen, S. Wang, and Y. Li, A simple, noninvasive and effi cient method for transdermal delivery of siRNA, Arch. Dermatol. Res., 304(2), 139–144 (2012). (90) T. Hsu, and S. Mitragotri, Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer, Proc. Natl. Acad. Sci. U S A, 108(38), 15816–15821 (2011). (91) T. Uchida, T. Kanazawa, Y. Takashima, and H. Okada, Development of an effi cient transdermal deliv- ery system of small interfering RNA using functional peptides, Tat and AT-1002, Chem. Pharm. Bull., 59(2), 196–201 (2011). (92) J.W. Lee, J.P. Tutela, R.A. Zoumalan, V.D. Thanik, P.D. Nguyen, L. Varjabedian, S.M. Warren, and P.B. Saadeh, Inhibition of Smad3 expression in radiation-induced fi brosis using a novel method for topical transcutaneous gene therapy, Arch. Otolaryngol. Head Neck Surg., 136(7), 714–719 (2010). (93) Y.X. Li, United States Patent application 2000/6117846. (94) T. Mammone, and M. Ingrassia, United States Patent application 1998/5800826. (95) M. Matsunaga, F. Yoshida, and T. Mori, United States Patent Application 20080161229. (96) M. Olejniczak, P. Galka, and W.J. Krzyzosiak, Sequence-non-specifi c effects of RNA interference triggers and microRNA regulators, Nucl. Acids. Res., 38(1), 1–16 (2010). (97) M. Robbins, A. Judge, and I. MacLachlan, siRNA and innate immunity, Oligonucleotide, 19(2), 89– 102 (2009). (98) A. Judge, and I. MacLachlan, Overcoming the innate immune response to small interfering RNA, Hum. Gene. Ther., 19(2), 111–124 (2008). (99) J.K. Watts and D.R. Corey, Clinical status of duplex RNA, Bioorg. Med. Chem. Lett.,20, 3203–3207 (2010). (100) F.T. Vicentini, L.V. Depieri, A.C. Polizello, J.O. Del Ciampo, A.C. Spadaro, and M.C. Fantini, Liquid crystalline phase nanodispersions enable skin delivery of siRNA, Eur. J. Pharm. Biopharm., 83(1), 16–24 (2013).